This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Apolipoprotein E (ApoE) has three common variants among humans, differing at two residues in the 299-residue protein. Variant ApoE2 has cysteines at residues 112 and 158;ApoE3 has a cysteine at 112 and an arginine at 158;and ApoE4 has arginines at both residues. No high resolution structure of any variant has been determined, owing to the oligomeric properties of the full protein. The first X-ray crystal structure of ApoE 23-164 revealed a four helix bundle structure of the N-terminal domain. No high resolution structure of the isolated C-terminal domain has been determined, and it is thought that this domain is the primary region of oligomeric interaction. ApoE4 carries the highest risk of any genetic factor for Alzheimer's disease (AD). There is evidence for several mechanisms of ApoE4-associated AD risk, though there is no consensus. Significantly, ApoE4 has a higher preference of forming VLDL lipoproteins than does the other common ApoE variants, and this has been attributed to a conformation involving an N-terminal:C-terminal domain interaction enhanced in ApoE4 by a possible salt bridge between R61 and E255. There is a significant need for a fundamental understanding of the lipid-free ApoE structure, to help unravel the physiological consequence of mutation C158R. The central problem inhibiting the structural characterization of ApoE is oligomerization. We have access to two mutants of ApoE3, monomeric to 20 mg/mL, and possessing similar lipid-binding and LDL receptor-binding properties of ApoE3. We intend to study the oligomerization as a starting point in a long-term project to understand the interactions of ApoE and the Abeta polypeptides.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Biotechnology Resource Grants (P41)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-BCMB-K (40))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Internal Medicine/Medicine
Schools of Medicine
Saint Louis
United States
Zip Code
Lucey, Brendan P; Mawuenyega, Kwasi G; Patterson, Bruce W et al. (2017) Associations Between ?-Amyloid Kinetics and the ?-Amyloid Diurnal Pattern in the Central Nervous System. JAMA Neurol 74:207-215
Lin, Xiaobo; Racette, Susan B; Ma, Lina et al. (2017) Endogenous Cholesterol Excretion Is Negatively Associated With Carotid Intima-Media Thickness in Humans. Arterioscler Thromb Vasc Biol 37:2364-2369
Cade, W Todd; Levy, Philip T; Tinius, Rachel A et al. (2017) Markers of maternal and infant metabolism are associated with ventricular dysfunction in infants of obese women with type 2 diabetes. Pediatr Res 82:768-775
Ovod, Vitaliy; Ramsey, Kara N; Mawuenyega, Kwasi G et al. (2017) Amyloid ? concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimers Dement 13:841-849
Wei, Xiaochao; Song, Haowei; Yin, Li et al. (2016) Fatty acid synthesis configures the plasma membrane for inflammation in diabetes. Nature 539:294-298
Shields-Cutler, Robin R; Crowley, Jan R; Miller, Connelly D et al. (2016) Human Metabolome-derived Cofactors Are Required for the Antibacterial Activity of Siderocalin in Urine. J Biol Chem 291:25901-25910
Mertins, Philipp; Mani, D R; Ruggles, Kelly V et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534:55-62
Murata, Takahiro; Dietrich, Hans H; Horiuchi, Tetsuyoshi et al. (2016) Mechanisms of magnesium-induced vasodilation in cerebral penetrating arterioles. Neurosci Res 107:57-62
Hölttä, Mikko; Dean, Robert A; Siemers, Eric et al. (2016) A single dose of the ?-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans. Alzheimers Res Ther 8:11
Sterl, Karin; Wang, Songyan; Oestricker, Lauren et al. (2016) Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery. Peptides 82:76-84

Showing the most recent 10 out of 693 publications